NEW HAVEN, Conn. (AP) _ Achillion Pharmaceuticals Inc. (ACHN) on Wednesday reported a loss of $19.3 million in its third quarter.
The New Haven, Connecticut-based company said it had a loss of 14 cents per share.
The results exceeded Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 18 cents per share.
In the final minutes of trading on Wednesday, the company's shares hit $3.90. A year ago, they were trading at $6.20.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ACHN at https://www.zacks.com/ap/ACHN